KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $2.7 billion.

  • Organon's Total Current Liabilities fell 397.85% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year decrease of 397.85%. This contributed to the annual value of $2.7 billion for FY2024, which is 685.4% down from last year.
  • Per Organon's latest filing, its Total Current Liabilities stood at $2.7 billion for Q3 2025, which was down 397.85% from $2.8 billion recorded in Q2 2025.
  • In the past 5 years, Organon's Total Current Liabilities ranged from a high of $3.1 billion in Q3 2021 and a low of $2.3 billion during Q1 2022
  • Its 5-year average for Total Current Liabilities is $2.6 billion, with a median of $2.6 billion in 2025.
  • In the last 5 years, Organon's Total Current Liabilities tumbled by 2559.92% in 2022 and then skyrocketed by 1616.24% in 2023.
  • Organon's Total Current Liabilities (Quarter) stood at $2.6 billion in 2021, then dropped by 3.27% to $2.5 billion in 2022, then increased by 16.16% to $2.9 billion in 2023, then dropped by 6.85% to $2.7 billion in 2024, then fell by 1.43% to $2.7 billion in 2025.
  • Its last three reported values are $2.7 billion in Q3 2025, $2.8 billion for Q2 2025, and $2.6 billion during Q1 2025.